FDA.reportPublic FDA data

hyaluronidase, human recombinant 400 UNT in 2.5 ML Injection

RxCUI
1809542
RxNorm name
hyaluronidase, human recombinant 400 UNT in 2.5 ML Injection
Display name
hyaluronidase, human recombinant 400 UNT in 2.5 ML Injection
Full name
hyaluronidase, human recombinant 400 UNT in 2.5 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125402HyqviaImmune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7ca2c26f-4be2-48cd-be5b-486e350654bahyaluronidase, human recombinant 400 UNT in 2.5 ML Injection [PSN] · 2.5 ML hyaluronidase, human recombinant 160 UNT/ML Injection [SCD] · hyaluronidase, human recombinant 400 UNT per 2.5 ML Injection [SY]322These highlights do not include all the information needed to use HYQVIA ® safely and effectively. See full prescribing information for HYQVIA. HYQVIA ® [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration Initial U.S. Approval: 201420260204